/FirstString Research

Graduate Portfolio Company · Grant Funding | Life Sciences 

A clinical-stage biopharmaceutical company dedicated to delivering breakthrough solutions for inflammation and injury based medical conditions through a better understanding of the molecular and cellular context that define the underlying pathology. FirstString is focused on diseases associated with dysregulation of inflammatory processes and modulation of injury response, such as cutaneous radiation injury, radiation dermatitis, and wounds.

Visit Company Website 

By | 2018-12-07T18:51:37+00:00 August 16th, 2018|0 Comments